All treatments
Treatment
Eviplera 200 mg/25 mg/245 mg film-coated tablets clinical trials
2 indexed studies · 0 currently recruiting
- Ongoing, recruitingTherapeutic use (Phase IV)
Study on Pharmacokinetics of newly developed ANtiretroviral agents in HIV-infected pregNAnt women (PANNA)
This study looks at how HIV medicines work in pregnant women. Researchers want to understand how the medicines are absorbed, used, and leave the body during and after pregnancy, and how they might affect babies. It's for women living with HIV who are pregnant or have recently given birth.
For: HIV-infectedSpain · Ireland · Netherlands - Ongoing, recruitingTherapeutic use (Phase IV)
Phase IV comparative, randomized, open-label pilot study to evaluate the efficacy and safety of a rilpivirine-based antiretroviral treatment regimen in HIV-infected patients with metabolic liver disease who maintain undetectable HIV viral load
This study looks at how well a specific HIV treatment helps people with both HIV and liver problems. It compares a new medicine combination to standard treatments to see if it improves liver health over 18 months.
For: Metabolic liver disease in HIV-infected peopleSpain